Portfolio company
GlucoSet
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
The company develops an intravascular sensor that provides continuous blood glucose monitoring for critically ill patients in intensive care units.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Advanced Perfusion Diagnostics
This company develops single-use devices for non-invasive, continuous microcirculation assessment and early sepsis detection for clinicians in critical care and surgical settings.
SepsiScan
This company develops bedside imaging devices for real-time microcirculation monitoring and early sepsis diagnosis for intensive care units and hospitals.
Sensys
This company develops non-invasive blood glucose monitors using infrared spectroscopy for patients managing diabetes.
Sencilia
This company develops non-invasive flow sensors for monitoring intravenous infusion therapy in neonatal and paediatric intensive care units.
Sensible Healthcare Systems
This company develops reusable continuous glucose monitoring sensors for people living with diabetes.
Flosonics Medical
This company develops wearable Doppler ultrasound sensors that monitor blood flow for clinicians treating patients in emergency and intensive care settings.
Luciole Medical AG
This company develops sensors and software to monitor brain oxygenation and blood flow for clinicians treating patients in neurocritical care and anaesthesia.
Medyria AG
The company develops sensor-equipped microcatheters that measure blood flow velocity for interventional cardiologists to diagnose ischemic heart conditions.